Table 1.
Case No. | Age/Sex | Cancer | Chemo Regimen | Cold Cap Usage Details | Onset | Follow-up†† | Potential contributory factors | |||
---|---|---|---|---|---|---|---|---|---|---|
Make | Pre-infusion | During infusion | Post-infusion | |||||||
1 | 49/F | Breast | TCHP | Penguin™ | 60′ | 2.5hrs. | 5hrs. | Cycle 3 | Mild persistent alopecia (at 5 months) | Lack of adequate padding between the cold cap and skin; duration of post-infusion cooling |
2 | 55/F | Breast | AC➔T | Elasto-Gel™ | 15′ | 60′ | 50mins. | Cycle 3 | Mild persistent alopecia (at 4 months) | Pre-existing alopecia; lack of padding; duration of post-infusion cooling? |
3 | 58/F | Breast | PH | Penguin™ | 50′ | 30′ | 2.5hrs. | Cycle 4† | Alopecia resolved (at 2 months) | Pre-existing diffuse alopecia; duration of post-infusion cooling |
4 | 50/F | Breast | CMF | Penguin™ | 50′ | 60′ | 4.5hrs. | Cycle 1 | Mild persistent alopecia, skin sensitivity (at 6 months) | Lack of adequate padding; duration of post-infusion cooling |
TCHP – docetaxel, carboplatin, trastuzumab, pertuzumab; AC-T – adriamycin and cyclophosphamide, followed by paclitaxel; PH – paclitaxel, trastuzumab; CMF – cyclophosphamide, methotrexate, fluorouracil
this includes two complete cycles of paclitaxel and two cycles of albumin-bound paclitaxel
it must be noted that the findings occurred in some patients, despite the use of topical minoxidil 5% lotion